Physician

Chakradhar Madhavareddigari Reddy, M.D

According to 2025 Medicare claims, Chakradhar Reddy, M.D (NPI: 1548360332) practices internal medicine in the Johnson City, TN market, with the plurality of this provider's patient population coming from Washington, TN. This provider's primary affiliated billing organization is GASTROINTESTINAL ASSOCIATES OF NORTHEAST TENNESSEE, PC (NPI: 1578529632; TIN: 621508557) and primary practice location at 37604-6008.

Reddy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 523 traditional Medicare patients, billed 7,580 HCPCS/CPT codes, and received $200,386 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 993 prescription claims across 539 beneficiaries totaling $168,653 in drug costs, led by Xifaxan (Rifaximin). 2019 DME data shows 15 claims. Open Payments data shows 116 records totaling $156,927. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $3,723,345 to $168,653. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	506	1,171	$110,620
2016	561	1,460	$125,596
2017	591	1,422	$121,498
2018	550	1,290	$107,162
2019	566	1,349	$111,014
2020	481	1,139	$98,136
2021	501	1,163	$105,482
2022	544	1,576	$143,807
2023	485	2,918	$126,741
2024	523	7,580	$200,386

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	393	1,434	$3,723,345
2016	414	1,426	$2,623,302
2017	459	1,536	$2,904,952
2018	466	1,394	$2,394,997
2019	480	1,450	$1,311,187
2020	449	1,382	$569,326
2021	569	1,588	$815,045
2022	534	1,262	$736,389
2023	569	1,059	$251,226
2024	539	993	$168,653

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	15	$2,641
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	119	120	$204
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	67	68	$91
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	130	158	$86
43235	Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope	62	64	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	101	117	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xifaxan	Rifaximin	29	812	$96,490
Motegrity	Prucalopride Succinate	12	420	$7,063
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	96	103	$5,755
Sutab	Sod Sulf/Pot Chloride/Mag Sulf	27	62	$4,072
Colestipol Hcl	Colestipol Hcl	39	1,850	$2,038

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$35,483	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	36	$121,444	Janssen Research & Development, LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chakradhar Madhavareddigari Reddy, M.D?

Tedicare shows public-source Medicare data for Chakradhar Madhavareddigari Reddy, M.D (NPI 1548360332), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chakradhar Madhavareddigari Reddy, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chakradhar Madhavareddigari Reddy, M.D?

Chakradhar Madhavareddigari Reddy, M.D is linked to GASTROINTESTINAL ASSOCIATES OF NORTHEAST TENNESSEE, PC (billing NPI 1578529632) in the available physician profile data.

Does Chakradhar Madhavareddigari Reddy, M.D have Open Payments data?

Chakradhar Madhavareddigari Reddy, M.D has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.